LESCHLY MARK
CIK: 0001120545
Director
Primary company: NITROMED INC (NTMD)
LESCHLY MARK is a corporate insider at NITROMED INC (NTMD) filing SEC Form 4 transactions. 152 transactions across 7 companies, totaling $24,503,000 in purchases and $1,473,674 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 1,336 | - | - | 47,761 | 7/21/2026 Filed: 7/21/2026 | Filing → | |
| Award | 6,680 | - | - | 46,425 | 7/21/2026 Filed: 7/21/2026 | Filing → | |
| Award | 18,370 | - | - | 39,745 | 7/21/2026 Filed: 7/21/2026 | Filing → | |
| Award | 254,785 | - | - | 427,517 | 7/8/2025 Filed: 7/9/2025 | Filing → | |
| Award | 115,552 | - | - | 172,732 | 7/9/2024 Filed: 7/11/2024 | Filing → | |
| Award | 21,925 | $0.00 | $0 | 57,180 | 7/18/2023 Filed: 7/20/2023 | Filing → | |
| Award | 13,563 | $0.00 | $0 | 35,255 | 7/12/2022 Filed: 7/14/2022 | Filing → | |
| Award | 3,192 | $0.00 | $0 | 21,692 | 7/12/2021 Filed: 7/14/2021 | Filing → | |
| J | 12,650 | $0.00 | $0 | 420,946 | 7/1/2021 Filed: 7/2/2021 | Filing → | |
NGM BIOPHARMACEUTICALS INC NGM | Award | 19,619 | $0.00 | $0 | 19,619 | 6/8/2021 Filed: 6/10/2021 | Filing → |
| Award | 18,500 | $0.00 | $0 | 18,500 | 5/27/2021 Filed: 6/1/2021 | Filing → | |
| J | 25,300 | $0.00 | $0 | 408,296 | 3/19/2021 Filed: 3/23/2021 | Filing → | |
| Award | 382,996 | - | - | 382,996 | 2/26/2021 Filed: 3/2/2021 | Filing → | |
NGM BIOPHARMACEUTICALS INC NGM | Award | 16,806 | $0.00 | $0 | 16,806 | 5/20/2020 Filed: 5/22/2020 | Filing → |
NGM BIOPHARMACEUTICALS INC NGM | Award | 24,000 | $0.00 | $0 | 24,000 | 5/15/2019 Filed: 5/17/2019 | Filing → |
NGM BIOPHARMACEUTICALS INC NGM | Conversion | 166,667 | $0.00 | $0 | 0 | 4/8/2019 Filed: 4/10/2019 | Filing → |
NGM BIOPHARMACEUTICALS INC NGM | Conversion | 600,000 | $0.00 | $0 | 0 | 4/8/2019 Filed: 4/10/2019 | Filing → |
NGM BIOPHARMACEUTICALS INC NGM | Conversion | 3,000,000 | $0.00 | $0 | 0 | 4/8/2019 Filed: 4/10/2019 | Filing → |
NGM BIOPHARMACEUTICALS INC NGM | Conversion | 3,766,667 | - | - | 3,766,667 | 4/8/2019 Filed: 4/10/2019 | Filing → |
Anacor Pharmaceuticals, Inc. ANAC | Disposition | 4,096 | - | - | 0 | 6/24/2016 Filed: 6/24/2016 | Filing → |
Type
Award
Shares
1,336
Price
-
Value
-
Type
Award
Shares
6,680
Price
-
Value
-
Type
Award
Shares
18,370
Price
-
Value
-
Type
Award
Shares
254,785
Price
-
Value
-
Type
Award
Shares
115,552
Price
-
Value
-
Type
Award
Shares
21,925
Price
$0.00
Value
$0
Type
Award
Shares
13,563
Price
$0.00
Value
$0
Type
Award
Shares
3,192
Price
$0.00
Value
$0
Type
J
Shares
12,650
Price
$0.00
Value
$0
NGM BIOPHARMACEUTICALS INC
NGM
Type
Award
Shares
19,619
Price
$0.00
Value
$0
Type
Award
Shares
18,500
Price
$0.00
Value
$0
Type
J
Shares
25,300
Price
$0.00
Value
$0
Type
Award
Shares
382,996
Price
-
Value
-
NGM BIOPHARMACEUTICALS INC
NGM
Type
Award
Shares
16,806
Price
$0.00
Value
$0
NGM BIOPHARMACEUTICALS INC
NGM
Type
Award
Shares
24,000
Price
$0.00
Value
$0
NGM BIOPHARMACEUTICALS INC
NGM
Type
Conversion
Shares
166,667
Price
$0.00
Value
$0
NGM BIOPHARMACEUTICALS INC
NGM
Type
Conversion
Shares
600,000
Price
$0.00
Value
$0
NGM BIOPHARMACEUTICALS INC
NGM
Type
Conversion
Shares
3,000,000
Price
$0.00
Value
$0
NGM BIOPHARMACEUTICALS INC
NGM
Type
Conversion
Shares
3,766,667
Price
-
Value
-
Anacor Pharmaceuticals, Inc.
ANAC
Type
Disposition
Shares
4,096
Price
-
Value
-
AI Agent
Try asking...